Welcome to the Cycling Anti-Doping Foundation (CADF) website. The role of the CADF is to manage the anti-doping programme on behalf of the Union Cycliste Internationale (UCI). Created in 2008, the CADF is a non-profit foundation under Swiss law that became fully independent and ISO certified in 2013.
Welcome to the Cycling Anti-Doping Foundation (CADF) website. The role of the CADF is to manage the anti-doping programme on behalf of the Union Cycliste Internationale (UCI). Created in 2008, the CADF is a non-profit foundation under Swiss law that became fully independent and ISO certified in 2013.
Welcome to the Cycling Anti-Doping Foundation (CADF) website. The role of the CADF is to manage the anti-doping programme on behalf of the Union Cycliste Internationale (UCI). Created in 2008, the CADF is a non-profit foundation under Swiss law that became fully independent and ISO certified in 2013.
To find more about the CADF activities in 2017, please read MORE
Aigle, Switzerland, July 4th, 2018 – Today, the Cycling Anti-Doping Foundation (CADF), the independent organisation mandated by the Union Cycliste Internationale (UCI) to define and manage the fight against doping in cycling, announced its strategy for the 2018 Tour de France starting on Saturday 7th July, which will be implemented in close cooperation with the Agence Française de Lutte contre le Dopage (AFLD), the National Anti-Doping Organisation of France. MORE
On 14 June 2018, the CADF Funding Committee met in Geneva and welcomed two new members : Amina Lanaya, Director General of the Union Cycliste Internationale (UCI) and Luc Gheysens, representing the race organisers’ association (AIOCC).
MORE
The CADF is delighted to communicate the appointment of Mr. Andy Parkinson as new member of the CADF Foundation Board.
Mr. Andy Parkinson is the Chief Executive Officer of British Rowing, having joined the organisation in this role in January 2015.
MORE
An intelligence-led doping test was carried out by the CADF in collaboration with the AFLD (Agence Française de Lutte contre le Dopage) and the OCLAEPS (Office Central de Lutte contre les Atteintes à l‘Environnement et la Santé Publique) on March the 8th 2018 on the French Rider Rémy Di Gregorio during the UCI WorldTour race Paris-Nice. The test returned an Adverse Analytical Finding (AAF) for Darbepoetin (dEPO)*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.ch/pressreleases/uci-statement-remy-gregorio/) * dEPO is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List.”
To Riders and Support Personnel The 2018 Prohibited List comes into effect on 1 January 2018. It is highly recommended that all Riders and Support Staff take the time to familiarize themselves with this important information. (Several languages below)
Cycling Anti-Doping Foundation
Ch. de la Mêlée 12
CH 1860 Aigle
Switzerland
